Potential side effects of semaglutide drug with history of mental health Recent findings have sparked a renewed discussion about the side effects of semaglutide, a GLP-1 receptor agonist, and its potential link to suicide and self-harm. Complications An in-depth analysis of data from the World Health Organization’s postmarketing surveillance database suggests a possible association between…
Explosive New Study Unmasks weight loss drug black marketing A groundbreaking study has unearthed a troubling of weight loss drug black marketing, illegal online pharmacies are peddling potentially dangerous versions of the renowned drugs Wegovy and Ozempic. These semaglutide-based medications, celebrated for their efficacy in treating diabetes and obesity, are now at the heart of…
The Counterfeit Drug Example of Lifesaving Drugs Found in Delhi, Jharkhand India, renowned for its pharmaceutical industry, faces a troubling menace as counterfeit drug versions of critical lifesaving medicines have been uncovered in Delhi and Jharkhand. The Central Drugs Standard Control Organization, India’s apex drug regulator, recently sounded the alarm after identifying counterfeit iterations of…
let’s explore weight loss drug spending worldwide Survey on weight loss drug spending worldwide reveals Consumer Willingness to Invest in Weight Loss Drugs: Health and Science Perspective Americans are notably # 1 in weight loss drug spending worldwide,they are spending significantly more on these drugs compared to their counterparts in other countries. Despite limited insurance…
The Obesity Epidemic: A Pharmacist’s Perspective on World Obesity Day 4 March 2024 As the world grapples with the ever-growing obesity epidemic, pharmacists stand at the frontline, playing a pivotal role in combating this multifaceted health crisis. Today, on World Obesity Day 2024, we reflect on the challenges and opportunities ahead in our mission to…
Zepbound Emerges as a Potent Rival: FDA Approves Dual Hormone Activator for Weight Loss Drug Potent weight loss drug ,Zepbound distinguishes itself in weight loss medications with its dual activation of GLP-1 and GIP receptors, a unique feature not shared by counterparts like Wegovy or Ozempic. This dual-hormone approach offers a more comprehensive mechanism, potentially…
Protecting Patients: how to recognize counterfeit drugs Austria recently witnessed a disturbing incident, where several individuals ended up in the hospital after using suspected counterfeit versions of Novo Nordisk’s Ozempic, a medication vital for managing type 2 diabetes. This alarming occurrence not only underscores the dangers posed by counterfeit pharmaceuticals but also the urgent need…
Wegovy Launch in the UK: A New Frontier in Weight Loss Introduction: The UK’s battle against obesity receives a powerful ally as Novo Nordisk introduces Wegovy, a groundbreaking weight loss injection. This article explores the significance of the Wegovy launch in the UK and how it can transform the weight loss landscape. Obesity, a prevalent…
doctors in the operation theatre
An Investigation into Syndromic Childhood Obesity: Breaking Genetic Barriers Syndromic childhood obesity is a complex and devastating condition that requires careful medical attention, early detection, and management strategies to improve the outcomes for affected individuals Childhood obesity is a critical health concern that has captured the attention of researchers, medical professionals, and policymakers worldwide. While…
